Company: IMNN
Filing Date: 2025-06-09
Form Type: DEF 14A
Source: 0001641172-25-014324
Chunk: 101

Company: Imunon, Inc.
Filing Date: 2025-06-09
Form: DEF 14A
Chunk 101
---
 price or base price per share), the terms of each outstanding Stock Award (including the number and class of securities subject thereto), the terms of each outstanding Performance Award (including the number and class of securities subject thereto, if applicable) shall be appropriately adjusted by the Committee, such adjustments to be made in the case of outstanding options and SARs in accordance with Section 409A of the Code. In the event of any other change in corporate capitalization, including a merger, consolidation, reorganization, or partial or complete liquidation of the Company, such equitable adjustments described in the foregoing sentence may be made as determined to be appropriate and equitable by the Committee to prevent dilution or enlargement of rights of participants. In either case, the decision of the Committee regarding any such adjustment shall be final, binding and conclusive.

5.8 Change in Control.

(a) Subject to the terms of the applicable award Agreements, in the event of a “Change in Control,” the Board, as constituted prior to the Change in Control, may, in its discretion:

| (1) | require                                                                                                                                     
 that (i) some or all outstanding options and SARs shall become exercisable in full or in part, either immediately or upon a subsequent      
 termination of employment, (ii) the Restriction Period applicable to some or all outstanding Stock Awards shall lapse in full or            
 in part, either immediately or upon a subsequent termination of employment, (iii) the Performance Period applicable to some or all          
 outstanding awards shall lapse in full or in part, and (iv) the Performance Measures applicable to some or all outstanding awards           
 shall be deemed to be satisfied at the target, maximum or any other level;                                                                  |
| (2) | require                                                                                                                                     
 that shares of capital stock of the corporation resulting from or succeeding to the business of the Company pursuant to such Change         
 in Control, or a parent corporation thereof, be substituted for some or all of the shares of Common Stock subject to an outstanding         
 award, with an appropriate and equitable adjustment to such award as determined by the Board in accordance with Section 5.7;                
 and/or                                                                                                                                      |
| (3) | require                                                                                                                                     
 outstanding awards, in whole or in part, to be surrendered to the Company by the holder, and to be immediately cancelled by the Company,    
 and to provide for the holder to receive (i) a cash payment in an amount equal to (A) in the case of an option or an SAR, the aggregate     
 number of shares of Common Stock then subject to